帕金森病脑深部电刺激治疗的性别差异
结果显示女性术前病程更长、运动症状更重、用药剂量更低、生活质量更差;术后1年女性认知域评分随时间恶化,但运动症状改善无性别差异。
要点
- 女性帕金森病患者接受丘脑底核脑深部电刺激时病程更长、术前运动症状更重。
- 术后1年运动症状改善在男女间无显著差异,但女性认知域评分恶化。
- 女性术前多巴胺能药物剂量更低、生活质量更差,提示治疗时机可能偏晚。
核心结论
- 丘脑底核脑深部电刺激对男女帕金森病患者临床疗效相当,但女性治疗时机更晚。
- 女性术前处于更晚期阶段,运动症状更重且生活质量更差。
- 术后女性认知指数评分更差,该指数反映情绪而非认知。
研究设计与样本
- 采用统一帕金森病评定量表第三部分评估运动症状,左旋多巴等效日剂量评估多巴胺能药物用量,39项帕金森病问卷评估生活质量。
- 使用探索性线性混合效应模型分析性别与时间对上述评分的交互作用。
主要发现
- 术前女性病程显著更长(p=0.014),停药状态下统一帕金森病评定量表第三部分评分更高(p<0.001)。
- 术前女性左旋多巴等效日剂量更低(p=0.001),39项帕金森病问卷平均总分更差(p<0.001)。
- 术后1年,调整病程、年龄、停药状态评分和左旋多巴等效日剂量后,39项帕金森病问卷认知域存在显著性别与时间交互作用,女性随时间恶化(p=0.009)。
- 停药/刺激状态下统一帕金森病评定量表第三部分评分无显著性别与时间交互作用。
临床怎么用
- 临床应关注女性帕金森病患者接受脑深部电刺激评估时病程更长、症状更重的问题。
- 术后随访需关注女性患者认知域评分变化,该评分可能反映情绪状态。
- 运动症状改善在男女间相当,选择脑深部电刺激适应证时不应因性别而区别对待。
局限性
- 本研究为单中心回顾性队列研究。
- 样本量有限,女性仅26例。
- 认知指数被作者视为情绪代理指标而非认知功能本身。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studies have suggested that there may be sex differences in the preoperative characteristics and postoperative outcomes of patients with Parkinson's disease (PD) treated with subthalamic nucleus (STN) deep brain stimulation (DBS). Authors of this study aimed to reveal differences in preoperative and 1-year postoperative motor symptoms, dopaminergic medication use, and quality of life (QOL) domains between men and women who had undergone STN DBS. METHODS: In this retrospective cohort study, the authors evaluated patients who underwent bilateral STN DBS at a single center from 2008 to 2023. Motor symptoms were measured using the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III), levodopa equivalent daily dose (LEDD) was used to measure the dosage of dopaminergic medications, and the 39-Item Parkinson's Disease Questionnaire (PDQ-39) was used to determine QOL outcomes. Exploratory linear mixed-effect models were used to investigate sex and time interactions for the UPDRS-III, LEDD, and PDQ-39 scores. RESULTS: Ninety-four patients, 26 females and 68 males, were included in the study. Preoperatively, women presented with a significantly longer disease duration (p = 0.014), greater UPDRS-III off-medication scores (p < 0.001), lower LEDDs (p = 0.001), and worse PDQ-39 mean total score (p < 0.001). One year postoperatively, after adjusting for disease duration, age, UPDRS-III off scores, and LEDD, there was a significant sex and time interaction for the cognition domain of the PDQ-39, which showed worsening over time in women (p = 0.009). There was no significant sex and time interaction in the UPDRS-III off-medication/on-stimulation scores. CONCLUSIONS: Although STN DBS is equally clinically efficacious for both sexes, women are treated later in the disease course. Preoperatively, women present during more advanced stages of PD with worse motor symptoms and a lower QOL. Postoperatively, women score worse on the cognition index, a proxy for mood rather than cognition.
引用
- Faran M, Pietramala DA, Schmidt FA, et al. Sex disparity in patients with Parkinson's disease treated using deep brain stimulation. J Neurosurg. 2025. PMID: 40378492. doi:10.3171/2025.1.JNS241670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。